KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Revenue (2016 - 2025)

Historic Revenue for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q3 2025 value amounting to $889000.0.

  • CRISPR Therapeutics AG's Revenue rose 4767.44% to $889000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $38.3 million, marking a year-over-year decrease of 8109.89%. This contributed to the annual value of $37.3 million for FY2024, which is 8994.79% down from last year.
  • According to the latest figures from Q3 2025, CRISPR Therapeutics AG's Revenue is $889000.0, which was up 4767.44% from $892000.0 recorded in Q2 2025.
  • CRISPR Therapeutics AG's Revenue's 5-year high stood at $900.7 million during Q2 2021, with a 5-year trough of $6000.0 in Q4 2022.
  • Moreover, its 5-year median value for Revenue was $877000.0 (2025), whereas its average is $73.7 million.
  • Per our database at Business Quant, CRISPR Therapeutics AG's Revenue tumbled by 9998.25% in 2022 and then skyrocketed by 335333333.33% in 2023.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Revenue stood at $12.9 million in 2021, then tumbled by 99.95% to $6000.0 in 2022, then surged by 3353333.33% to $201.2 million in 2023, then tumbled by 82.26% to $35.7 million in 2024, then plummeted by 97.51% to $889000.0 in 2025.
  • Its Revenue was $889000.0 in Q3 2025, compared to $892000.0 in Q2 2025 and $865000.0 in Q1 2025.